Author:
Josephson Michelle A.,Javaid Basit,Kadambi Pradeep V.,Meehan Shane M.,Williams James W.
Reference66 articles.
1. Chong AS, Huang W, Liu W et al. In vivo activity of leflunomide: Pharmacokinetic analyses and mechanism of immunosuppression. Transplantation 1999; 68:100–109.
2. Kuchle CC, Thoenes GH, Langer KH et al. Prevention of kidney and skin graft rejection in rats by leflunomide, a new immunomodulating agent. Transplant Proc 1991; 23:1083–1086.
3. Lin Y, Waer M. In vivo mechanism of action of leflunomide: Selective inhibition of the capacity of B lymphocytes to make T-independent xenoantibodies. Transplant Proc 1996; 28:3085.
4. Lin Y, Goebels J, Xia G et al. Induction of specific transplantation tolerance across xenogeneic barriers in the T-independent immune compartment. Nat Med 1998; 4:173–180.
5. Williams JW, Xiao F, Foster P et al. Leflunomide in experimental transplantation. Control of rejection and alloantibody production, Reversal of acute rejection, and interaction with cyclosporine. Transplantation 1994; 57:1223–1231.
Cited by
7 articles.
订阅此论文施引文献
订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献